THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,610,000 | -6.0% | 144,619 | +6.9% | 0.01% | -16.7% |
| Q3 2016 | $4,902,000 | +59.5% | 135,265 | -0.1% | 0.01% | +50.0% |
| Q2 2016 | $3,073,000 | +43.0% | 135,449 | +18.5% | 0.00% | +33.3% |
| Q1 2016 | $2,149,000 | +27.8% | 114,300 | +11.4% | 0.00% | +50.0% |
| Q4 2015 | $1,681,000 | +57.5% | 102,583 | +5.7% | 0.00% | +100.0% |
| Q3 2015 | $1,067,000 | -15.9% | 97,093 | -0.4% | 0.00% | -50.0% |
| Q2 2015 | $1,269,000 | +5.9% | 97,491 | +41.1% | 0.00% | 0.0% |
| Q1 2015 | $1,198,000 | +17.2% | 69,071 | +0.9% | 0.00% | +100.0% |
| Q4 2014 | $1,022,000 | -35.8% | 68,488 | -0.8% | 0.00% | -50.0% |
| Q3 2014 | $1,591,000 | -27.4% | 69,013 | +0.4% | 0.00% | -33.3% |
| Q2 2014 | $2,190,000 | – | 68,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |